MedTech Innovator
Offers early-stage medtech startups up to $500,000 through its yearly accelerator.
Roughly one in five applicants gets invited to pitch, and that shortlist is chosen with input from MedTech Innovator's corporate partners as well as staff reviewing the applications, not staff alone. Every company invited to pitch gets a PDF feedback summary from the judging panel afterward, whether or not it advances, and those judges include investors and senior executives from companies like Jo…
MedTech Innovator accepts early- to mid-stage medical device, diagnostic and digital health companies, with prototypes and some proof-of-concept evidence preferred. Companies that have raised up to a Series C are eligible.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
DocumentsGrant Pitch Deck Example: Slides, Storyline, and Video Script
See a grant pitch deck example with slide outline, EIC-style pitch logic, demo-video script, and grant-vs-investor deck differences.
Start hereDeep Tech Funding Playbook 2026
Data-driven guide for deeptech founders raising capital, covering valuations, investor expectations, fundraising tactics, and a map of 1,200+ deeptech funds.
Similar grants
Browse the directory →
Childhood, Adolescent and Young Adult (AYA) Cancer Data Innovation Challenge — Track 1
🇺🇸NCI · United States
Pays entities up to $566,665 across three milestones to add shovel-ready cancer data or tools to NCI's CCDI ecosystem.
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge
🇺🇸NIH · United States
Awards up to $13.1 million across three phases to US-based teams developing novel technologies that target RNA to treat human disease.
TRDNT Challenge Phase II: Prototype Development and Use Case Demonstration
🇺🇸NIH · United States
Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.
One-Step, Rapid, Low-Cost Definitive Drug Testing at the Point of Need Challenge
🇺🇸NIDA · United States
Pays up to $600,000 in prizes to teams building rapid, low-cost drug-testing device prototypes.
Unlocking Urologic Oncology Innovation QuickFire Challenge
🇺🇸J&J Innovation · United States
Supports innovators designing bladder and prostate cancer therapies and surgical tools through a J&J urologic oncology challenge.
RADx Tech ACT ENDO Challenge
🇺🇸NICHD · United States
Paid $3 million in prizes for non-invasive technologies that speed up endometriosis diagnosis.